Acceptance reflects the high interest of the SIR scientific committee on the emerging role of endovascular robotics Acceptance reflects the high interest of the SIR scientific committee on the emerging role of endovascular robotics
Author: Ken Dropiewski
Cagent Vascular Announces Launch of New Product Serranator SL-PRO for CLTI and Pedal Disease
WAYNE, Penn.–(BUSINESS WIRE)–Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, today announced the launch of its newest product, Serranator SL-PRO™ PTA Serration Balloon Catheter. “As an experienced Serranator operator, my team has grown accustomed to the benefits of Serration including great lumen gain, […]
Vascular Verification Program Verifies First Community Hospital
CHICAGO (January 3, 2025): Intermountain Health St. Mary’s Regional Hospital in Grand Junction Colorado was awarded ACS/SVS Vascular-VP designation on November 19, 2024. By achieving this prestigious status, Intermountain Health St. Mary’s Regional Hospital shows their commitment to delivering high quality treatment for patients receiving vascular surgical and interventional care […]
RapidAI Secures FDA 510(k) Clearance for Groundbreaking AI 3D Head and Neck CTA Imaging: Lumina 3D™
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in AI-driven medical imaging analysis and coordinated care, has received FDA 510(k) clearance for Lumina 3D™ by RapidAI—an industry-first, automated 3D imaging reconstruction solution designed to replace manual workflows with an AI-powered approach based on the latest groundbreaking AI technology advances. “Obtaining high-quality […]
Surmodics Announces Successful Early Clinical Use of Pounce™ XL Thrombectomy System, Suitable for Non-Surgical Removal of Thrombi and Emboli from Iliac and Femoral Arteries
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the successful early clinical use of its Pounce™ XL Thrombectomy System. The Pounce XL Thrombectomy System received U.S. Food and Drug Administration (FDA) 510(k) clearance […]
BrightHeart Unveils Breakthrough AI Results at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, Revolutionizing Prenatal Care
PARIS–(BUSINESS WIRE)–BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, presented two groundbreaking studies during the oral plenary and concurrent sessions on January 30th at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, held in Aurora, Colorado. As the first major unveiling of the […]
GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand
anuary 31, 2025 03:00 AM Eastern Standard Time CHALFONT ST. GILES, England–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill and finish manufacturing site in Ireland. A new state-of-the-art facility on the grounds of the existing site will enable 25 […]
Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results
January 30, 2025 07:00 AM Eastern Standard Time EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2024. “We were pleased with the efforts of our […]
Viz.ai and Illuminate Expand Partnership to Improve Cerebral Aneurysm Patient Care
SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced an expanded partnership with Softek Illuminate, Inc., an industry leader in the development of proprietary natural language processing (NLP) and AI software that discovers at-risk patients from electronic medical records (EMR), assesses disease severity, and […]
Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis
Robust evidence of the clinical benefit of WINREVAIR demonstrated in the STELLAR and ZENITH studies resulted in a loss of clinical equipoise in the HYPERION study January 30, 2025 06:45 AM Eastern Standard Time RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced […]
Recent
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026
TruLeaf Medical, a fully-owned subsidiary of Allmed Solutions successfully Completed the Second Stage of valve implantation in two Additional Patients
Popular
- No commented posts yet